The Experts below are selected from a list of 105 Experts worldwide ranked by ideXlab platform
B. J. Tindall - One of the best experts on this subject based on the ideXlab platform.
-
The subgenus names Moraxella and Branhamella (in the genus Moraxella) are not in accordance with the International Code of Nomenclature of Bacteria and are therefore not validly published: Supplementary information to Opinion 83. Judicial Commission
International journal of systematic and evolutionary microbiology, 2014Co-Authors: B. J. TindallAbstract:The publication of Opinion 83, which dealt with the valid publication of the subgenus names Moraxella and Branhamella (in the genus Moraxella), has highlighted a problem relating to the absence of descriptions associated with these names at the time they were effectively published. This calls into question whether the ruling outlined in Opinion 83, that these names should have qualified for inclusion on the Approved Lists of Bacterial Names, and their inclusion on Validation List 15 are not in accordance with Rule 27 of the International Code of Nomenclature of Bacteria governing the valid publication of a name. The subgenus names Moraxella and Branhamella (in the genus Moraxella) are not to be considered to be included on the Approved Lists of Bacterial Names, nor are they to be considered to be validly published by inclusion on Validation List 15.
-
The subgenus names Moraxella subgen. Moraxella and Moraxella subgen. Branhamella and the species names included within these taxa should have been included on the Approved Lists of Bacterial Names and a ruling on the proposal to make changes to Rule
International Journal of Systematic and Evolutionary Microbiology, 2008Co-Authors: B. J. TindallAbstract:The Judicial Commission of the International Committee for Systematics of Prokaryotes rules that the following names should have been included on the Approved Lists of Bacterial Names, Moraxella (subgen. Branhamella Bovre 1979), Moraxella (subgen. Moraxella Lwoff 1939), Moraxella (subgen. Branhamella Bovre 1979) catarrhalis, Moraxella (subgen. Branhamella Bovre 1979) caviae, Moraxella (subgen. Branhamella Bovre 1979) ovis, Moraxella (subgen. Moraxella Lwoff 1939) atlantae, Moraxella (subgen. Moraxella Lwoff 1939) bovis, Moraxella (subgen. Moraxella Lwoff 1939) lacunata, Moraxella (subgen. Moraxella Lwoff 1939) nonliquefaciens, Moraxella (subgen. Moraxella Lwoff 1939) osloensis, Moraxella (subgen. Moraxella Lwoff 1939) phenylpyruvica. Proposals to alter Rule 34a were rejected.
Gary V. Doern - One of the best experts on this subject based on the ideXlab platform.
-
The Moraxella and Branhamella Subgenera of the Genus Moraxella
The Prokaryotes, 1992Co-Authors: Gary V. DoernAbstract:The Moraxella genus is comprised of two subgenera, Moraxella and Branhamella (Bovre, 1984). Within the Moraxella subgenus are found six clearly delineated species: M. (M.) lacunata, the type species of this subgenus, M. (M.) nonliquefaciens, M. (M.) atlantae, M. (M.) phenylpyruvica, and M (M.) osloensis. In addition, there is one species of uncertain taxonomic status, M. urethralis (species incertae sedis). The Branhamella subgenus consists of four species: M. (B.) catarrhalis, the type species of this subgenus, M. (B.) caviae, M. (B.) ovis, and M. (B.) cuniculi.
-
In vitro activity of ceftibuten against Haemophilus influenzae and Branhamella catarhallis.
Diagnostic microbiology and infectious disease, 1991Co-Authors: Gary V. DoernAbstract:The in vitro activity of ceftibuten, a new orally administered cephalosporin, was assessed against clinical isolates of Haemophilus influenzae and Branhamella catarrhalis. The activity of ceftibuten was compared to that of ampicillin, amoxicillin-clavulanic acid, and three oral cephalosporins, cefaclor, cefuroxime, and cefixime. With the exception of rare beta-lactamase-negative ampicillin-resistant strains of H. influenzae, resistance to ceftibuten was not observed with any of the study isolates. Ceftibuten was more active than amoxicillin/clavulanic acid for beta-lactamase-positive and -negative strains of H. influenzae; it was less active than this combination for B. catarrhalis. Ceftibuten was essentially equivalent in activity to cefixime against both Haemophilus and Branhamella but more active than cefaclor and cefuroxime against these two organisms.
B. W. Catlin - One of the best experts on this subject based on the ideXlab platform.
-
Notes: Branhamaceae fam. nov., a Proposed Family To Accommodate the Genera Branhamella and Moraxella
International Journal of Systematic and Evolutionary Microbiology, 1991Co-Authors: B. W. CatlinAbstract:The genera assigned to the family Neisseriaceae in 1984 (K. Bovre, p. 288-290, in N. R. Krieg and J. G. Holt, ed., Bergey's Manual of Systematic Bacteriology, vol. 1) are now recognized as members of two different groups (the beta and gamma groups) of the class Proteobacteria. DNA base composition data, findings from DNA-mediated transformation to streptomycin resistance, DNA-DNA hybridization, and DNA-rRNA hybridization, and results from electrophoresis of soluble proteins have revealed differences that mandate separation from Neisseria of the three species of “false neisseriae” (Neisseria caviae, Neisseria ovis, and Neisseria cuniculi), and also of the genera Branhamella, Moraxella, and Acinetobacter. Since these organisms must be excluded from the Neisseriaceae, the new family Branhamaceae is proposed to accommodate the genera Branhamella (including the false neisseriae) and Moraxella. This arrangement acknowledges the phylogenetic relationships of these organisms and resolves controversies concerning (i) the recommendation that the genus Moraxella should be divided into the subgenus Moraxella (for rod-shaped organisms) and the subgenus Branhamella (for cocci) and (ii) the taxonomic placement of the false neisseriae. The present evidence does not favor inclusion of the genus Acinetobacter in the family Branhamaceae. The following species are included at this time in the type genus, Branhamella: Branhamella catarrhalis (the type species), Branhamella caviae, Branhamella ovis, and Branhamella cuniculi. The species allocated at this time to the genus Moraxella are Moraxella lacunata (the type species) Moraxella bovis, Moraxella nonliquefaciens, Moraxella osloensis, Moraxella phenylpyruvica, and Moraxella atlantae.
J P Euzeby - One of the best experts on this subject based on the ideXlab platform.
-
nomenclature of the subgenera moraxella and Branhamella and of the nine species included in these subgenera and proposal to modify rule 34a of the bacteriological code 1990 revision request for an opinion
International Journal of Systematic and Evolutionary Microbiology, 2001Co-Authors: J P EuzebyAbstract:The subgenera Moraxella and Branhamella and the nine species included in these subgenera were inadvertently omitted from the Approved Lists of Bacterial Names and have never been revived according to Rule 28a of the Bacteriological Code (1990 Revision). The author requests that these names be revived and considered to be validly published in the 'Index of the bacterial and yeast nomenclatural changes published in the International Journal of Systematic Bacteriology since the 1980 Approved Lists of Bacterial Names (1 January 1980 to 1 January 1985)', which appears in the July 1985 issue of the International Journal of Systematic Bacteriology. Another problem is the status of the species included in the subgenera Moraxella and Branhamella because the Bacteriological Code (1990 Revision) does not envisage the status of a species transferred into a subgenus. The same is true for a species transferred into a subspecies. The author requests that such species be considered as new combinations and, according to this, proposes to modify Rule 34a of the Bacteriological Code (1990 Revision).
Steven L. Berk - One of the best experts on this subject based on the ideXlab platform.
-
Lack of inhibition of sodium polyanethol sulfonate (SPS) on recovery of Moraxella (Branhamella) catarrhalis from blood cultures
Journal of Microbiological Methods, 1992Co-Authors: James W. Myers, Fawwaz Hamati, Sean N. Dooley, Shirley A. Berk, Steven L. BerkAbstract:Abstract Moraxella (Branhamella) catarrhalis , although commonly isolated from sputum in patients with pneumonia, rarely causes bacteremia. Sodium polyanethol sulfonate is commonly added to routine blood culture media to increase the yield of Gram-negative bacilli. This anticoagulant also inhibits the growth of Neisseria meningitidis . We added strains f Moraxella (Branhamella) catarrhalis to routine blood culture media supplemented with 0.03% SPS. No inhibitory effect could be demonstrated. The rare occurrence of bacteremic Moraxella (Branhamella) catarrhalis pneumonia is not due to an inhibitory effect of routine blood culture media.
-
Moraxella (Branhamella) catarrhalis.
Infectious disease clinics of North America, 1991Co-Authors: Abraham Verghese, Steven L. BerkAbstract:Moraxella (Branhamella) catarrhalis is now a well-recognized pathogen in lower respiratory tract infections, particularly in the setting of chronic lung disease. The ability to produce beta-lactamase, which now characterizes most clinical strains, appears to be a recently acquired trait. The most common clinical syndrome caused by this organism is exacerbation of chronic bronchitis; this syndrome has been well described in Europe, Japan, and the United States, particularly from centers with a large elderly population with chronic lung disease. The syndrome of pneumonia is less common, and suppurative complications and bacteremia are rare.